Randolph M. Johnson

3.0k total citations · 1 hit paper
39 papers, 2.4k citations indexed

About

Randolph M. Johnson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Randolph M. Johnson has authored 39 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Randolph M. Johnson's work include Nerve injury and regeneration (8 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Randolph M. Johnson is often cited by papers focused on Nerve injury and regeneration (8 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Randolph M. Johnson collaborates with scholars based in United States, Netherlands and Bulgaria. Randolph M. Johnson's co-authors include James C. Garrison, Ester B. Coronado, H. Michael Shepard, C. Kent Osborne, Debasish Tripathy, Jay Sarup, Christopher C. Benz, Gary K. Scott, David Fontana and Matthieu J. Guitton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Randolph M. Johnson

39 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1992 625 citations Christopher C. Benz, Gary K. Scott et al. Breast Cancer Research and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Randolph M. Johnson United States	21	977	552	502	328	298	39	2.4k
Kinga Szigeti United States	24	933 1.0×	333 0.6×	239 0.5×	812 2.5×	50 0.2×	64	2.9k
Carlos Río United States	14	850 0.9×	402 0.7×	136 0.3×	677 2.1×	32 0.1×	32	2.1k
Ling Shan China	32	855 0.9×	576 1.0×	192 0.4×	222 0.7×	33 0.1×	100	2.6k
Maria Teresa Dotti Italy	37	1.8k 1.8×	469 0.8×	537 1.1×	791 2.4×	27 0.1×	173	4.5k
Ulrich F. O. Luhmann United Kingdom	31	1.9k 2.0×	265 0.5×	195 0.4×	714 2.2×	118 0.4×	69	3.5k
Hiroyuki Higashiyama Japan	21	831 0.9×	157 0.3×	230 0.5×	777 2.4×	94 0.3×	35	2.6k
Brahim Nait‐Oumesmar France	35	1.9k 1.9×	151 0.3×	379 0.8×	1.1k 3.3×	128 0.4×	63	4.4k
Marı́a Santacana Spain	34	1.3k 1.4×	439 0.8×	177 0.4×	870 2.7×	27 0.1×	111	3.2k
Iver A. Langmoen Norway	36	1.5k 1.6×	511 0.9×	129 0.3×	1.4k 4.3×	59 0.2×	112	3.8k
Yasuo Nagai Japan	24	1.2k 1.2×	282 0.5×	155 0.3×	480 1.5×	50 0.2×	73	3.2k

Countries citing papers authored by Randolph M. Johnson

Since Specialization

Citations

This map shows the geographic impact of Randolph M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randolph M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randolph M. Johnson more than expected).

Fields of papers citing papers by Randolph M. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randolph M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randolph M. Johnson. The network helps show where Randolph M. Johnson may publish in the future.

Co-authorship network of co-authors of Randolph M. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Randolph M. Johnson. A scholar is included among the top collaborators of Randolph M. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randolph M. Johnson. Randolph M. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Songnan, Randolph M. Johnson, Jacqueline A. Carozza, et al.. (2025). ENPP1 inhibitor with ultralong drug-target residence time as an innate immune checkpoint blockade cancer therapy. Cell Reports Medicine. 6(9). 102336–102336. 2 indexed citations

Walter, Sarah, Amos Baruch, Shawn T. Alexander, et al.. (2014). Comparison of AMG 416 and cinacalcet in rodent models of uremia. BMC Nephrology. 15(1). 81–81. 20 indexed citations

Walter, Sarah, Amos Baruch, James Tomlinson, et al.. (2013). Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients. Journal of Pharmacology and Experimental Therapeutics. 346(2). 229–240. 84 indexed citations

Johnson, Randolph M., Stephen D. Harrison, & Derek Maclean. (2010). Therapeutic Applications of Cell-Penetrating Peptides. Methods in molecular biology. 683. 535–551. 93 indexed citations

Lee, James T., George I. Jallo, Margaret B. Penno, et al.. (2006). Intracranial drug-delivery scaffolds: Biocompatibility evaluation of sucrose acetate isobutyrate gels. Toxicology and Applied Pharmacology. 215(1). 64–70. 18 indexed citations

Johnson, Randolph M., et al.. (2004). Toxicity and Cerebrospinal Fluid Levels of Carboplatin Chronically Infused into the Brainstem of a Primate. Journal of Neuro-Oncology. 67(3). 327–334. 19 indexed citations

Guitton, Matthieu J., Jean Caston, Jérôme Ruel, et al.. (2003). Salicylate Induces Tinnitus through Activation of Cochlear NMDA Receptors. Journal of Neuroscience. 23(9). 3944–3952. 249 indexed citations

Hermans, J. J. Rob, Helma van Essen, Harry A.J. Struijker-Boudier, et al.. (2002). Pharmacokinetic Advantage of Intrapericardially Applied Substances in the Rat. Journal of Pharmacology and Experimental Therapeutics. 301(2). 672–678. 28 indexed citations

Verity, A. Neil, et al.. (1999). Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. Journal of Neuroscience Research. 55(2). 187–197. 62 indexed citations

10.

Kahle, Philipp J., Eric M. Shooter, Randolph M. Johnson, & A. Neil Verity. (1998). Phosphatidylcholine-Specific Phospholipase Inhibitor D609 Differentially Affects MAP Kinases and Immediate-Early Genes in PC12 Cells. Cellular Signalling. 10(5). 321–330. 4 indexed citations

11.

Emmett, C.J., et al.. (1997). EVALUATION OF HUMAN ASTROCYTOMA AND GLIOBLASTOMA CELL LINES FOR NERVE GROWTH FACTOR RELEASE. Neurochemistry International. 30(4-5). 465–474. 12 indexed citations

12.

Stewart, Gregory R., et al.. (1997). Hyperplastic Changes within the Leptomeninges of the Rat and Monkey in Response to Chronic Intracerebroventricular Infusion of Nerve Growth Factor. Experimental Neurology. 145(1). 24–37. 58 indexed citations

13.

Emmett, C.J., et al.. (1996). Distribution of Radioiodinated Recombinant Human Nerve Growth Factor in Primate Brain Following Intracerebroventricular Infusion. Experimental Neurology. 140(2). 151–160. 23 indexed citations

14.

Emmett, C.J., et al.. (1995). Dose-response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria fornix model of acute cholinergic degeneration. Brain Research. 673(2). 199–207. 19 indexed citations

15.

Johnson, Randolph M., et al.. (1994). Recombinant human ciliary neurotrophic factor stimulates the metabolic activity of SH-SY5Y cells as measured by a cytosensor microphysiometer. Brain Research. 646(2). 327–331. 12 indexed citations

16.

Fontana, David, et al.. (1994). Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission. Pharmacology Biochemistry and Behavior. 49(4). 1075–1082. 43 indexed citations

17.

Benz, Christopher C., Gary K. Scott, Jay Sarup, et al.. (1992). Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Research and Treatment. 24(2). 85–95. 625 indexed citations breakdown →

18.

Babich, Michael, et al.. (1991). Thrombin and Parathyroid Hormone Mobilize Intracellular Calcium in Rat Osteosarcoma Cells by Distinct Pathways^*. Endocrinology. 129(3). 1463–1470. 36 indexed citations

19.

Gross, Stephen R., et al.. (1983). The phosphorylase kinase activity of hearts from phosphorylase kinase-deficient mice. Biochemical Genetics. 21(7-8). 781–786. 1 indexed citations

20.

Gross, Stephen R. & Randolph M. Johnson. (1980). Role of extracellular Ca++ in regulating isoproterenol-stimulated phosphorylase a formation in murine skeletal muscle.. Journal of Pharmacology and Experimental Therapeutics. 214(1). 37–44. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact